Great Valley Advisor Group’s GSK GSK Stock Holding History

Great Valley Advisor Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$347K	Buy	6,281 +1,893	+43%	+$103K	0.01%	780
2025 Q4	$216K	Buy	+4,388	New	+$205K	﹤0.01%	879
2022 Q1	–	Sell	-10,890	Closed	-$600K	–	606
2021 Q4	$600K	Sell	10,890 -1,900	-15%	-$98.8K	0.04%	351
2021 Q3	$611K	Buy	12,790 +947	+8%	+$47.6K	0.04%	319
2021 Q2	$589K	Buy	11,843 +1,099	+10%	+$52.8K	0.04%	312
2021 Q1	$479K	Buy	10,744 +2,928	+37%	+$133K	0.05%	311
2020 Q4	$360K	Buy	+7,816	New	+$359K	0.04%	340

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Great Valley Advisor Group's GSK Position: Q1 2026 in Review

Great Valley Advisor Group increased its GSK (GSK) stake by 43% in Q1 2026, buying an estimated $103K and bringing the position to 6,281 shares worth $347K. The position accounts for 0.01% of the portfolio, ranked #780.

Great Valley Advisor Group first reported a position in GSK in Q4 2020 and has held it in 7 quarters since. The position peaked at $611K in Q3 2021. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Great Valley Advisor Group held 6,281 shares of GSK worth $347K as of Q1 2026.
Great Valley Advisor Group bought 1,893 GSK shares in Q1 2026, an estimated $103K.
GSK made up 0.01% of Great Valley Advisor Group's portfolio in Q1 2026, its #780 holding.
Great Valley Advisor Group first reported a position in GSK in Q4 2020 and has held it in 7 quarters since.
Great Valley Advisor Group's GSK position peaked at $611K in Q3 2021.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Great Valley Advisor Group's 13F filing for Q1 2026, filed 11 May 2026.